Перейти к основному содержанию
Back Все курсы

Separator

36 Доступно курсов

Precision Oncologydottime60 min

Precision oncology in practice – testing through to treatment in lung and prostate cancer

eaccme EACCME®
Precision Oncologydottime30 min

Diagnosis and treatment of TRK fusion-positive lung cancer

eaccme EACCME®
Precision Oncologydottime60 min

Diagnosing and treating TRK fusion-positive cancer

eaccme EACCME®
Precision Oncologydottime60 min

TRK fusion-positive sarcomas and lung cancer

eaccme EACCME®
Gastrointestinal Oncologydottime30 min

First- and second-line chemotherapy options in mPDAC

eaccme EACCME®
Gastrointestinal Oncologydottime30 min

Chemotherapy strategies for metastatic pancreatic ductal adenocarcinoma

Module 2 of 2
eaccme EACCME®
Gastrointestinal Oncologydottime30 min

Diagnosis and management of metastatic pancreatic ductal adenocarcinoma

Module 1 of 2
eaccme EACCME®
Gastrointestinal Oncologydottime30 min

Understanding the needs of different patient populations in CRC

eaccme EACCME®
Gastrointestinal Oncologydottime30 min

Long term management of advanced colorectal cancer

eaccme EACCME®
Gastrointestinal Oncologydottime60 min

Exploring the current gastroesophageal cancer treatment landscape and near-future developments

eaccme EACCME®
Gastrointestinal Oncologydottime60 min

Skin Toxicities Related to Targeted Therapy in GI and Liver Oncology

eaccme EACCME®accme ACCMEabim ABIM
Gastrointestinal Oncologydottime60 min

GUIDE Communication Framework

eaccme EACCME®
Genitourinary Oncologydottime30 min

Evolving landscape of PARP inhibitors in mCRPC: combination with anti-androgens

Module 2 of 2
eaccme EACCME®
Genitourinary Oncologydottime30 min

PARP inhibitors in Advanced Prostate Cancer

Module 1 of 2
eaccme EACCME®
Genitourinary Oncologydottime60 min

Incorporating PARP inhibitors into prostate cancer clinical practice

eaccme EACCME®
Genitourinary Oncologydottime60 min

Targeting advanced prostate cancer with PARP inhibitors: Who, When and How?

eaccme EACCME®
Liver Oncologydottime30 min

Advanced HCC: treatment strategies for patients ineligible for IO or those with progression on IO

Advanced HCC
eaccme EACCME®
Liver Oncologydottime30 min

The expanding role of immunotherapy (IO) in HCC: combining locoregional and systemic treatments in intermediate HCC

eaccme EACCME®
Liver Oncologydottime60 min

Treatment options for HCC patients who are not eligible for or progressed on IO

Clinical considerations and when to switch
eaccme EACCME®
Liver Oncologydottime30 min

The use of immunotherapy in HCC

Module 2: in-depth subgroup analyses and challenges
eaccme EACCME®
Liver Oncologydottime30 min

The use of immunotherapy in HCC

Module 1: efficacy and safety
eaccme EACCME®
Neonatology / Blood Gases and Transcutaneous Monitoring (TCM) in the NICU and PICUdottime60 min

Blood Gases and Transcutaneous Monitoring (TCM) in the NICU and PICU

eaccme EACCME®
Neuroendocrine Tumoursdottime30 min

Tools for optimising treatment & management of advanced NETs

eaccme EACCME®
Neuroendocrine Tumoursdottime30 min

Recognising, Diagnosing and Managing Neuroendocrine Tumours

eaccme EACCME®
Hemato-oncologydottime60 min

Optimising the management of multiple myeloma in the early relapsed/refractory setting (RRMM)

eaccme EACCME®
Hemostasisdottime60 min

Managing thrombosis: podcast series

eaccme EACCME®
Hemostasisdottime60 min

Normalising Haemostasis in Haemophilia - A new standard of care

eaccme EACCME®
Hemostasisdottime30 min

Von Willebrand disease in the emergency care setting

eaccme EACCME®
Hemostasisdottime30 min

Women with Bleeding Disorders

Module 1 – How to recognise bleeding disorders in women and girls
eaccme EACCME®
Hemostasisdottime30 min

Women with Bleeding Disorders

Module 2 - How to diagnose and manage women with bleeding disorders
eaccme EACCME®
Endocrinologydottime60 min

Current perspectives on childhood growth disorders

eaccme EACCME®
Endocrinologydottime30 min

Addressing diagnostic challenges of Severe Primary IGF-I Deficiency

eaccme EACCME®
Sarcomadottime30 min

Diagnosis and Management approach for Bone Sarcoma

eaccme EACCME®
Breast Cancerdottime60 min

HER2 testing: The evolving role of immunohistochemistry (IHC)

Best practices and interpretation of results in lung and ovarian cancer
eaccme EACCME®
Breast Cancerdottime60 min

New oral endocrine therapy options for patients with advanced or metastatic ER+ breast cancer

eaccme EACCME®
Dermatologydottime30 min

Improving acne vulgaris with multimodal treatment strategies

eaccme EACCME®